Large-scale testing (Phase 3)Study completedNCT03476239
What this trial is testing
Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 121